Home › Trial NCT01943058
Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer
- Trial IDNCT01943058
- StatusWithdrawn
- PhasePhase 2
- Study typeInterventional
- SponsorUniversity of Southern California
- Enrollment—
- Start date2014-03
- ConditionsAtypical Endometrial Hyperplasia · Endometrial Adenocarcinoma · Recurrent Endometrial Carcinoma · Stage IA Endometrial Carcinoma · Stage IB Endometrial Carcinoma · Stage II Endometrial Carcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.